Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Lenalidomide × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 73 Lymphoma, Follicular 20 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma, B-Cell, Marginal Zone 10 Recurrence 8 Lymphoma 8 Neoplasms, Plasma Cell 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Mantle-Cell 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Neoplasms 4 Neoplasm, Residual 3 Myelodysplastic Syndromes 3 Lymphoma, B-Cell 3 Smoldering Multiple Myeloma 2 Leukemia, Myelomonocytic, Chronic 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Paraproteinemias 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroblastoma 1 Lymphoproliferative Disorders 1

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 Radiotherapy, Intensity-Modulated 1 Pemetrexed 1 Paclitaxel 1 Nimorazole 1 Immunotherapy 1 Gemcitabine 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡